The government is committed to transform the country's entire healthcare landscape, Health Minister Mansukh Mandaviya said Wednesday, highlighting that this dispensation opened several new AIIMS, raised the number of medical colleges to almost double and operationalised more than 10,000 Jan Aushadhi Kendras. He was speaking after virtually inaugurating a Super Specialty Block at Ganesh Shankar Vidyarthi Memorial Medical College in Kanpur, Uttar Pradesh. He also laid the foundation stone of an All India Institute of Speech and Hearing (AIISH) Satellite Centre in Kanpur. "This Super Specialty Block offering 12 super-specialty services will help people take these specialised services locally, saving their valuable time and resources," he said. On the AIISH Centre in Kanpur, he said it will be the first such state-of-the-art centre in North India which will not only train doctors but also provide care to people. It is the dream of Prime Minister Narendra Modi that AIISH institutes be .
Aster DM earlier announced plans to separate its India and Gulf businesses in a deal valued at $1 billion
Private hospital chains are expected add over 30,000 beds at an investment of Rs 32,500 crore in the country over the next four to five years, rating agency Icra said on Wednesday. It expects the aggregate occupancy for its sample set companies to remain healthy at 64-65 per cent in FY24 backed by sustained healthy demand for healthcare services, continued market share gains for organised players and revival in medical tourism after the pandemic. "Overall, most private players are expected to add over 30,000 beds in the next four to five years at an investment of Rs 32,500 crore," ICRA Assistant Vice President & Sector Head Mythri Macherla said. Metro cities are expected to remain focal points for this capacity expansion, she added. Centres such as Delhi-NCR, Mumbai, and Bengaluru are expected to witness sizeable bed additions in the next few years, Mythri said. In addition to setting up new greenfield and brownfield facilities to enhance their capacities, hospital chains are also
Identifies key themes like leisure, jewellery, out-of-home food, healthcare and premium brands as growth areas
Akumentis Healthcare on Wednesday said it has introduced a drug for the treatment of epilepsy. The Mumbai-based company has launched Clasepi, a DCGI-approved prescription cannabidiol (CBD) specifically formulated to address seizures linked with Lennox-Gastaut Syndrome (LGS), Dravet Syndrome, or Tuberous Sclerosis Complex (TSC) in patients aged 1 year and older, it said in a statement. Clinical studies have demonstrated Clasepi's efficacy in reducing seizures, especially in cases where conventional anti-seizure medications have proven ineffective, it added. "We understand the immense physical and emotional toll that frequent seizures can have on patients and their families," Akumentis Executive Director Kanishk Jain said. This is the driving force behind our commitment to developing novel solutions that effectively relieves the complexities of these disorders, he added. According to the World Health Organisation (WHO), epilepsy constitutes a considerable portion of the global disea
The institute claims it will help people to choose alternatives to plastic and using edible crockery will also improve their health
The barometer release follows a year that was the hottest on record and saw escalating levels of conflict worldwide, but that also brought progress on climate action, trade agreements and innovation
As health anxieties rise, K Srinath Reddy's book explores linkages between health and biology, geography, economic means, and social stature, offering useful insights
The new cases of the Covid-19 sub-variant JN. 1 were detected across ten states and union territories
The cost of treatment, especially in countries like the US, is much higher than in India, which makes a large sum insured essential
The UN health agency said on Friday that reported cases of dengue globally increased tenfold over the last generation, with climate change and the growing spread of virus-carrying mosquitoes partly to blame for transmission that remains mostly prevalent in the Americas. The World Health Organisation said reported cases soared to a record 5.2 million in 2019, up from 500,000 in 2000, across 129 countries worldwide, figures that likely understate the actual toll. In January, WHO warned that dengue posed a pandemic threat and was the world's fastest spreading mosquito-borne disease. While there are vaccines and specially bred mosquitoes containing a bacteria called Wolbachia to fight dengue, there are no specific treatments for the virus once someone becomes infected. This year, more than 5 million cases and over 5,000 dengue-related deaths were reported, WHO said. Changing distribution patterns of the mosquitoes that spread dengue, together with higher rainfall, humidity and heat link
Cipla's move aligns with its vision to strengthen investments in channels and technologies
The Indian Pharmacopoeia Commission (IPC) states that painkiller Meftal can cause adverse reactions, including drug reactions with eosinophilia and systemic symptoms (DRESS) syndrome
Drug major Cipla on Sunday said its subsidiary is voluntarily recalling one lot of medication in the US due to seal integrity issues. InvaGen Pharmaceuticals Inc, USA, is voluntarily recalling one lot of Vigabatrin for Oral Solution, USP (500 mg), at the consumer level due to seal integrity issues, allowing for powder leakage from the pouch, the Mumbai-based drug maker said in a regulatory filing. An improper seal in the pouch may lead to the leakage of powder blend outside the pouch, resulting in a lower content of medicine inside the pack compared to the label claim and potential underdosing, it added. The population at risk is primarily infants and young children, Cipla said. In those patients, there is a reasonable probability that inaccurate dosing might result in a serious adverse effect, such as intoxication or breakthrough seizures, requiring medical intervention, it stated. For a small minority of patients, who might have severe or repeated breakthrough seizures, a drop i
Every year, at least 40 million women are likely to experience a long-term health problem caused by childbirth, new study published in The Lancet Global Health journal has found. Researchers found that the symptom of experiencing pain during sexual intercourse, or dyspareunia, affected more than a third of such postpartum women (35 per cent), while 32 per cent of these women experienced low back pain. Other symptoms affecting postnatal women included involuntary urination (8-31 per cent), anxiety (9-24 per cent), depression (11-17 per cent) and perineal pain (11 per cent), which refers to pain in the general region between the anus and the genital organs, the international team of researchers including those from the World Health Organization (WHO) said in their study. Their study showed that a high burden of postnatal conditions persisted in the months or even years after giving birth. However, many of these occur beyond the point where women typically have access to postnatal ...
This financial sanction will pave way for crucial infrastructure projects, including the construction of a science building at MBB College and a women's hostel at Gandatwisa Government Degree College
Approximately six crore hospital admissions entailing an expenditure of Rs 77,298 crore have been authorised under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana till November 30, Union Health Minister Mansukh Mandaviya told Lok Sabha on Friday. As of December 2, a total of 26,774 hospitals, including 11,733 private facilities, across the country have been empanelled to provide healthcare services to the scheme beneficiaries, he said, adding that 4.98 crore claims have been submitted between financial years 2020-21 and 2023-24 as of November 30. The AB PM-JAY is the largest publicly funded health assurance scheme in the world which aims to provide health cover of Rs 5 lakh per family yearly for secondary and tertiary care hospitalization to 12 crore families, the Union health minister said. He said AB PM-JAY provides health cover to families which constitute the bottom 40 per cent of the population. The budget allocated for Ayushman Bharat PM-JAY for the financial year 2023-24
Is India prepared for the next pandemic? What is holding back India's internet growth? What should you do with rate-sensitive stocks? What is Jeff Bezos' 10,000-year clock? All answers here